Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

Pfisterer, Jacobus; Shannon, Catherine M.; Baumann, Klaus; Rau, Joern; Harter, Philipp; Joly, Florence; Sehouli, Jalid; Canzler, Ulrich; Schmalfeldt, Barbara; Dean, Andrew P.; Hein, Alexander; Zeimet, Alain G.; Hanker, Lars C.; Petit, Thierry; Marme, Frederik; El-Balat, Ahmed; Glasspool, Rosalind; de Gregorio, Nikolaus; Mahner, Sven; Meniawy, Tarek M.; Park-Simon, Tjoung-Won; Mouret-Reynier, Marie-Ange; Costan, Cristina; Meier, Werner; Reinthaller, Alexander; Goh, Jeffrey C.; L'Haridon, Tifenn; Hay, Sally Baron; Kommoss, Stefan; du Bois, Andreas; Kurtz, Jean-Emmanuel

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

Author:

Pfisterer, Jacobus; Shannon, Catherine M.; Baumann, Klaus; Rau, Joern; Harter, Philipp; Joly, Florence; Sehouli, Jalid; Canzler, Ulrich; Schmalfeldt, Barbara; Dean, Andrew P.; Hein, Alexander; Zeimet, Alain G.; Hanker, Lars C.; Petit, Thierry; Marme, Frederik; El-Balat, Ahmed; Glasspool, Rosalind; de Gregorio, Nikolaus; Mahner, Sven; Meniawy, Tarek M.; Park-Simon, Tjoung-Won; Mouret-Reynier, Marie-Ange; Costan, Cristina; Meier, Werner; Reinthaller, Alexander; Goh, Jeffrey C.; L'Haridon, Tifenn; Hay, Sally Baron; Kommoss, Stefan; du Bois, Andreas; Kurtz, Jean-Emmanuel

Tübinger Autor(en):

Kommoss, Stefan

Published in:

Lancet Oncology (2020), Bd. 21, H. 5, S. 699-709

Verlagsangabe:

Elsevier Science Inc

Language:

English

Full text:

http://dx.doi.org/10.1016/S1470-2045(20)30142-X

ISSN:

1474-5488